scholarly journals Evaluation of intra-articular injection of bupivacaine with morphine or methylprednisolone or alone on pain after knee arthroscopy

Background and Aim: Knee arthroscopy is used to diagnose and treat intra-articular lesions. Controlling acute pain after arthroscopy requires the use of a method with the least side effects and the most efficiency. The aim of this study was to compare the sedative effect after intra-articular injection of bupivacaine combination with morphine or methylprednisolone or alone in knee arthroscopy. Materials and Methods: In this study clinical-randomized three-blind trial, 99 volunteer patients with knee arthroscopy were randomly divided into three groups: 1. Bupivacaine (0.5%), 2. Morphine (5 mg)+ bupivacaine (0.5%) and 3. Methylprednisolone (40 mg) + bupivacaine (0.5%). At the end of the operation, drugs were injected intra-articular and the amount of postoperative pain was evaluated and recorded based on visual analog scales 6, 12, 18, and 24 hours after injection. Also, receiving the injected analgesic within 24 hours, was recorded. Data were analyzed using SPSS software and repeated measures analysis of variance. Results: In all three groups, the pain intensity decreased significantly over time. The pain intensity of the methylprednisolone + bupivacaine and morphine+bupivacaine group was the similar, at different postoperative periods, but the pain intensity of these groups was significantly lower than the control. Also, consumption of the analgesics was significantly reduced in methylprednisolone+bupivacaine group compared to the two other groups. Conclusion: The results of this study showed that intra-articular injection of methylprednisolone + bupivacaine and morphine+bupivacaine was more effective than bupivacaine alone in reducing pain and the need for injectable analgesia.

2012 ◽  
Vol 2012 ◽  
pp. 1-12
Author(s):  
Rachel E. Maddux ◽  
Lars-Gunnar Lundh

The present study assessed the rate of depressive personality (DP), as measured by the self-report instrument depressive personality disorder inventory (DPDI), among 159 clients entering psychotherapy at an outpatient university clinic. The presenting clinical profile was evaluated for those with and without DP, including levels of depressed mood, other psychological symptoms, and global severity of psychopathology. Clients were followed naturalistically over the course of therapy, up to 40 weeks, and reassessed on these variables again after treatment. Results indicated that 44 percent of the sample qualified for DP prior to treatment, and these individuals had a comparatively more severe and complex presenting disposition than those without DP. Mixed-model repeated-measures analysis of variance was used to examine between-groups changes on mood and global severity over time, with those with DP demonstrating larger reductions on both outcome variables, although still showing more symptoms after treatment, than those without DP. Only eleven percent of the sample continued to endorse DP following treatment. These findings suggest that in routine clinical situations, psychotherapy may benefit individuals with DP.


2020 ◽  
pp. bmjspcare-2020-002618
Author(s):  
Azam Dehghani ◽  
Ali Hajibagheri ◽  
Ismail Azizi-Fini ◽  
Fatemeh Atoof ◽  
Noushin Mousavi

BackgroundPain is a common complication after laparoscopic surgery. This study aimed to examine the effect of an early mobilisation programme on postoperative pain intensity after laparoscopic surgery.MethodsA randomised controlled clinical trial was conducted on 80 patients who underwent laparoscopic surgery in Shahid Beheshti Hospital in Kashan, Iran. The patients were randomly allocated to intervention (n=40) and a control (n=40) group. In the intervention group, an early mobilisation programme was implemented in two rounds. The patient’s perceived pain was assessed using a Visual Analogue Scale 15 min before and 30 min after each round of early mobilisation. Data were analysed through the independent samples t, χ2 and Fisher’s exact tests and the repeated measures analysis.ResultsThe repeated measures analysis showed that the mean pain scores have been decreased over time (F=98.88, p<0.001). Considering the observed interaction between time and the intervention, the t test was used for pairwise comparisons and showed that the mean pain score was not significantly different between the two groups in 15 min before the first round of early mobilisation (p=0.95). However, the mean pain in the intervention group was significantly less than the control group in all subsequent measurements (p<0.05).ConclusionEarly mobilisation programmes such as the one implemented in the current study are easy and inexpensive and can be implemented safely for the reduction of pain after laparoscopic surgeries.


DICP ◽  
1989 ◽  
Vol 23 (7-8) ◽  
pp. 588-590 ◽  
Author(s):  
Linda S. Bullock ◽  
Joseph F. Fitzgerald ◽  
Helen I. Mazur

The stability of intravenous famotidine in dextrose 5% injection (D5W), NaCl 0.9% injection (NS), and sterile water for injection stored in polyvinyl chloride (PVC) syringes at 4°C for 14 days was studied. The concentration of famotidine samples was determined at time 0, 7 days, and 14 days by reverse-phase high-performance liquid chromatography. Samples were inspected for visual changes and tested for changes in pH. Results of the HPLC analysis indicated that the famotidine samples remained within 94-100 percent and 99-103 percent of the time 0 concentrations at 7 and 14 days, respectively. Repeated measures analysis of variance demonstrated a significant time effect on famotidine concentration as concentrations changed over time (p<0.01). This change was small in magnitude, however, and concentrations decreased at 7 days and increased at 14 days. Famotidine is stable at a concentration of 2 mg/mL in D5W, NS, and sterile water for injection stored in PVC syringes at 4°C for 14 days.


ISRN Surgery ◽  
2011 ◽  
Vol 2011 ◽  
pp. 1-6 ◽  
Author(s):  
Christian Bacci ◽  
Giulia Cassetta ◽  
Bruno Emanuele ◽  
Mario Berengo

The aim of this study was to assess the efficacy of Normast 300 mg in reducing swelling and pain after the surgical extraction of impacted lower third molars. Materials and Methods. A randomized, split-mouth, single-blind study was conducted on 30 patients between 18 and 30 years of age requiring lower third molar extraction. Patients underwent bilateral extractions in a randomized sequence, one extraction being performed under Normast treatment. The Normast treatment involved 2 tablets a day for 15 days. The parameters assessed at each procedure were trismus, swelling, pain, NSAID consumption, postoperative complications, drug tolerability, and safety. The results obtained were processed using repeated measures analysis of variance. Results. Perceived postoperative pain was reportedly significantly milder on Normast treatment than control. The trend of the means differed over time (P<.0001) and between the two extraction groups (P<.0221). On the other hand, for edema and trismus, the trend differed over time for both groups but did not differ between the two groups. Discussion. Our analyses indicate that patients experienced significantly less postoperative pain when they were treated with Normast. Conclusions. Administering Normast improves the postoperative course—in terms of pain—after lower third molar extraction.


1994 ◽  
Vol 165 (1) ◽  
pp. 113-116 ◽  
Author(s):  
Arthur Rifkin ◽  
Seshagiri Doddi ◽  
Basawaraj Karajgi ◽  
Michael Borenstein ◽  
Ralph Munne

BackgroundWe compared three doses of a neuroleptic as a treatment for mania.MethodForty-seven newly admitted in-patients with mania were randomised to receive 10, 30, or 80 mg a day of oral haloperidol, under double-blind conditions for up to six weeks. All subjects received prophylactic benztropine.ResultsRepeated-measures analysis of variance and survival analysis showed no difference in outcome by the different doses. Excluding drop-outs (38%), most of whom left the study during the first two weeks, 72% of the subjects responded. Side-effects were minimal; there were no differences among the three doses. Non-responders received more adjunctive lorazepam than responders.ConclusionsThe limited data suggest that more than 10 mg a day of haloperidol offers no advantage in mania.


2021 ◽  
Vol 38 (1) ◽  
pp. 50-61
Author(s):  
Jorge Eduardo Castresana ◽  
Laura Elena Puhl

The peach aphid Myzus persicae (Sulzer) and cotton aphid Aphis gossypii (Clover) (Hemiptera: Aphididae) are considered to be key pests affecting greenhouse pepper crops in Argentina as a result of their frequent occurrence and the seriousness of the damage caused by their feeding behavior and the transmission of virus. The goal of this research was to determine the efficiency of botanical products to control aphids and their side effects on parasitoids in this crop. Thus, three biorational pest control formulations derived from essential oils (EO) and plant extracts (Es) were tested, namely (i) neem EO, cinnamon EO, clove EO, oregano EO and American marigold EO (formulation 1); (ii) garlic EO and cinnamon EO (formulation 2); (iii) garlic E and rue E (formulation 3); and a soy lecithin adjuvant (lecithin), and finally, a control (water spray method). For this research, a completely randomized design was replicated 3 times. These treatments were applied directly to the foliage by means of a backpack sprayer on a weekly basis until the end of this trial. Subsequently, the total number of healthy aphids and parasitized aphids (mummies) on every leaf was recorded in the field and the laboratory through repeated measures Analysis of Variance (ANOVA) and LSD Fisher method. The results showed that formulation 1 and formulation 3 recorded a lower number of aphids and mummies compared to the other treatments. This evidence would demonstrate that these formulations repel aphids and parasitoids without the lethal effects caused by the use of broad spectrum insecticides.


2015 ◽  
Vol 33 (29_suppl) ◽  
pp. 191-191
Author(s):  
Sriram Yennu ◽  
Janet L. Williams ◽  
Minjeong Park ◽  
Diane D Liu ◽  
Eduardo Bruera

191 Background: Psychostimulant clinical trials on CRF in pts with advanced cancer suggest mixed effects on CRF. The aim of this study was to determine the effects of MP and placebo (PL) on the pts with clinically significant CRF and associated symptoms such as depression, sedation, or depression and sedation (couplets). Methods: Secondary analysis of pts who received MP as a part of 3 prospective controlled clinical trials on MP for CRF. Pts were categorized one of 4 groups, fatigue+depression (FD), fatigue+ drowsiness (FDR), fatigue+drowsiness+depression (FDDR) or fatigue only (F), and outcomes were change in FACIT-F subscale and ESAS -fatigue scores at Day 8 of treatment with MP and PL. Repeated measures analysis was applied to assess the effects of treatment over time (Day8 – Day0) among the 4 groups on FACIT-F subscale and ESAS fatigue. Results: Of the 322 evaluable pts (34 FD, 100 FDR, 78 FDDR, 107F), at Day 8 there was a significant improvement in the ESAS fatigue in MP compared to PL groups [median (IQR)-2 (-4, -1) vs 2 (-3.5,0),p = 0.03, but the difference in the change of FACIT-F between the groups was not significant [median(IQR) 8(2,17) VS7(0,12), p = 0.09). Repeated measures analysis on FACIT-F with pairwise interactions(Time X Baseline Group, Time X Treatment) shows that regardless of treatment, the increase of FACIT-F from Day0 to Day8 was significantly different between FD and F (p = 0.001) and between FDDR and F (p = 0.03).However the change over time was not significantly different between two treatment groups (p = 0.23). Furthermore, the repeated measure analysis including three term interactions(Time X Treatment X Baseline Group) indicates no significant the treatment effect on FACIT-F over time is not significantly different among the four groups (p = 0.89). Similarly, there is no significant treatment effect in ESAS fatigue score over time among the four groups. Conclusions: Although there was a general improvement in CRF (FACIT-F) scores over time, there was no significant treatment effect on this improvement over time among F or FD, or FDR, or FDDR groups defined by fatigue/depression/sedation in the whole study population. Further studies are needed.


2017 ◽  
Vol 16 (1) ◽  
pp. 177-177
Author(s):  
Dennis Boye Larsen ◽  
Thomas Graven-Nielsen ◽  
Rogerio Pessoto Hirata ◽  
Shellie A. Boudreau

Abstract Aims Muscle pain affects corticomotor areas representing the affected muscle, by changing the size of representation and reduces the corticospinal output as assessed by transcranial magnetic stimulation (TMS). Less work has been done to understand how pain in one muscle group may affect synergistic ipsilateral muscles distal to the pain. This study aimed to explore the effects of acute extensor carpi radialis (ECR) muscle pain on TMS motor-evoked potentials (MEPs) of the ECR and the first dorsal interosseus (FDI) muscle, which are known to strongly overlap within the corticomotor area. Methods Eight healthy volunteers (1 woman) were injected with hypertonic saline (5.8%, 0.5 mL) into the ECR muscle. Pain intensity was assessed by the visual analogue scale (VAS) every minute for 10 min. TMS was applied at 120% of ECR resting motor threshold, and MEPs were acquired from the ECR and the FDI muscles. At baseline, 10 TMS pulses were delivered. Temporal mapping of ECR and FDI MEPs over 10 min duration was performed by delivering 100 single-pulses of TMS, at 6 s interstimulus-interval. The MEPs for each muscle were averaged at baseline, peak-pain (1 –2 min epoch), and 10 min post-injection Results Pain intensity reduced significantly at 10 min postinjection as compared to peak-pain (P = 0.011). Further, one-way repeated measures analysis of variance revealed that ECR MEPs were altered at peak-pain compared to baseline (P > 0.05), but not 10 min post-injection (P > 0.05). Baseline and 10 min post-injection of ECR MEPs did not differ significantly (P = 0.67). The MEPs of the FDI muscle did not show a similar alteration over time (P = 0.1). Conclusions Despite the overlap between ECR and FDI representations, acute muscle pain of the ECR only significantly altered cortical excitability of the ECR muscle representation.


2019 ◽  
Vol 20 (6) ◽  
pp. 746-751
Author(s):  
Hoon Suk Park ◽  
Woo Jeong Kim ◽  
Joonsung Choi ◽  
Hyung Wook Kim ◽  
Jun Hyun Baik ◽  
...  

Introduction: Previous studies have revealed that vascular access resistance is constant during hemodialysis, but differs according to vascular access type. It is possible that intra-access flow volume (Qac) variation during hemodialysis may also differ according to vascular access type. We conducted this study to investigate whether there are differences in Qac according to vascular access type during hemodialysis. Methods: A total of 58 lower-arm arteriovenous fistula, 14 lower-arm arteriovenous graft, 27 upper-arm arteriovenous fistula, and 45 upper-arm arteriovenous graft cases were studied. Three consecutive Qac values (at 30, 120, and 240 min after the start of hemodialysis) were measured in each patient by the ultrasound dilution technique. Variations in Qac over time were analyzed using repeated measures analysis of variance and multivariate regression analyses, to assess the impact of different factors on Qac variation. Results: The repeated measures analysis of variance revealed that a significant interaction exists between time and vascular access type (p < 0.001). This suggests that vascular access type affects Qac change (%) variation over time during hemodialysis. In a multivariate analysis, mean arterial pressure change during hemodialysis (p = 0.009), access type (p < 0.001), and access location (p < 0.001) were independent variables causing Qac change variation. Conclusion: This study showed that there is a significant difference in Qac variation according to vascular access type during hemodialysis and that arteriovenous graft (vs arteriovenous fistula) and the lower-arm location (vs upper arm) were associated with a decrease in Qac during hemodialysis. This suggests that consideration of vascular access type is required to minimize Qac variation during hemodialysis.


2021 ◽  
pp. 1-11
Author(s):  
Martina Kovari ◽  
Jan Stovicek ◽  
Jakub Novak ◽  
Michaela Havlickova ◽  
Sarka Mala ◽  
...  

BACKGROUND: Anorectal dysfunction (ARD), especially bowel incontinence, frequently compromises the quality of life in multiple sclerosis (MS) patients. The effect of rehabilitation procedures has not been clearly established. OBJECTIVE: To determine the effect of an individualized rehabilitation approach on bowel incontinence and anorectal pressures. METHODS: MS patients with ARD underwent 6-months of individually targeted biofeedback rehabilitation. High resolution anorectal manometry (HRAM) and St. Mark’s Fecal Incontinence Scores (SMIS) were completed prior to rehabilitation, after 10 weeks of supervised physiotherapy, and after 3 months of self-treatment. RESULTS: Ten patients (50%) completed the study. Repeated measures analysis of variance (ANOVA) demonstrated significant improvement in the SMIS questionnaire over time [14.00 baseline vs. 9.70 after supervised physiotherapy vs. 9.30 after self-treatment (p = 0.005)]. No significant improvements over time were noted in any HRAM readings: maximal pressure [49.85 mmHg baseline vs. 57.60 after supervised physiotherapy vs. 60.88 after self-treatment (p = 0.58)], pressure endurance [36.41 vs. 46.89 vs. 49.95 (p = 0.53)], resting pressure [55.83, vs 52.69 vs. 51.84 (p = 0.704)], or area under the curve [230.0 vs. 520.8 vs. 501.9 (p = 0.16)]. CONCLUSIONS: The proposed individualized rehabilitation program supports a positive overall effect on anorectal dysfunction in MS patients.


Sign in / Sign up

Export Citation Format

Share Document